HLS Therapeutics Inc.

HLS Therapeutics Inc.verified

HLTRF

Price:

$2.51

Market Cap:

$79.80M

HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular (CV) markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsules; and PERSERIS, an injectable risperidone product for the treatment of schizophrenia. It also offers MyCare psychiatry lab assays and MyCare Insite point of care therapeutic drug-level monitoring tests. In addition, the company holds the U.S. marketing rights of Absorica, a commercial stage dermatology product; ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2010-01-27

Stock Exchange

PNK

Ticker

HLTRF

The Enterprise Value as of December 2024 (TTM) for HLS Therapeutics Inc. (HLTRF) is 130.88M

According to HLS Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 130.88M. This represents a change of -19.08% compared to the average of 161.74M of the last 4 quarters.

HLS Therapeutics Inc. (HLTRF) Historical Enterprise Value (quarterly & annually)

How has HLTRF Enterprise Value performed in the past?

The mean historical Enterprise Value of HLS Therapeutics Inc. over the last ten years is 294.87M. The current 130.88M Enterprise Value has changed 4.34% with respect to the historical average. Over the past ten years (40 quarters), HLTRF's Enterprise Value was at its highest in in the December 2019 quarter at 621.30M. The Enterprise Value was at its lowest in in the December 2014 quarter at -46938476.00.

Quarterly (TTM)
Annual

Average

294.87M

Median

250.66M

Minimum

-11571976.20

Maximum

603.27M

HLS Therapeutics Inc. (HLTRF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of HLS Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 169.93%

Maximum Annual Enterprise Value = 603.27M

Minimum Annual Increase = -1564.89%

Minimum Annual Enterprise Value = -11571976.20

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023189.56M-39.20%
2022311.76M-30.38%
2021447.79M-14.80%
2020525.58M-12.88%
2019603.27M51.11%
2018399.23M169.93%
2017147.90M-10.70%
2016165.63M-2.29%
2015169.52M-1564.89%
2014-11571976.20-200.66%

HLS Therapeutics Inc. (HLTRF) Average Enterprise Value

How has HLTRF Enterprise Value performed in the past?

The current Enterprise Value of HLS Therapeutics Inc. (HLTRF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

316.37M

5-year avg

415.59M

10-year avg

294.87M

HLS Therapeutics Inc. (HLTRF) Enterprise Value vs. Peers

How is HLTRF’s Enterprise Value compared to its peers?

HLS Therapeutics Inc.’s Enterprise Value is greater than Aion Therapeutic Inc. (7.26M), less than Cipher Pharmaceuticals Inc. (293.94M), greater than Cannara Biotech Inc. (104.72M), less than Knight Therapeutics Inc. (511.01M), greater than Canntab Therapeutics Limited (194.55K), greater than Bionoid Pharma Inc. (6.05M), greater than Crescita Therapeutics Inc. (3.19M), greater than CENTR Brands Corp. (1.22M), greater than RAMM Pharma Corp. (529.77K), less than Craftport Cannabis Corp. (9.02B), greater than Speakeasy Cannabis Club Ltd. (2.88M), greater than City View Green Holdings Inc. (2.86M), greater than RavenQuest BioMed Inc. (13.59M), greater than Lowell Farms Inc. (18.42M),

Build a custom stock screener for HLS Therapeutics Inc. (HLTRF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HLS Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

HLS Therapeutics Inc. (HLTRF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like HLS Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is HLS Therapeutics Inc.'s Enterprise Value?

What is the highest Enterprise Value for HLS Therapeutics Inc. (HLTRF)?

What is the 3-year average Enterprise Value for HLS Therapeutics Inc. (HLTRF)?

What is the 5-year average Enterprise Value for HLS Therapeutics Inc. (HLTRF)?

How does the current Enterprise Value for HLS Therapeutics Inc. (HLTRF) compare to its historical average?